BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16803480)

  • 1. Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients.
    Tawfik El-Mansi M; Cuschieri KS; Morris RG; Williams AR
    Int J Gynecol Cancer; 2006; 16(3):1025-31. PubMed ID: 16803480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus genotypes in cervical cancer and precursor lesions.
    Hadzisejdić I; Simat M; Bosak A; Krasević M; Grahovac B
    Coll Antropol; 2006 Dec; 30(4):879-83. PubMed ID: 17243564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.
    Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT;
    J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of High risk Human Papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan.
    Gul S; Murad S; Javed A
    Int J Infect Dis; 2015 May; 34():14-9. PubMed ID: 25725135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities.
    de Oliveira ER; Derchain SF; Sarian LO; Rabelo-Santos SH; Gontijo RC; Yoshida A; Andrade LA; Zeferino LC
    Int J Gynecol Cancer; 2006; 16(3):1055-62. PubMed ID: 16803485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
    Quint KD; de Koning MN; Geraets DT; Quint WG; Pirog EC
    Gynecol Oncol; 2009 Sep; 114(3):390-4. PubMed ID: 19500822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
    Carozzi FM; Tornesello ML; Burroni E; Loquercio G; Carillo G; Angeloni C; Scalisi A; Macis R; Chini F; Buonaguro FM; Giorgi Rossi P;
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2389-400. PubMed ID: 20826836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma.
    Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
    Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
    Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
    Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran.
    Esmaeili M; Bonyadi M; Dastranj A; Alizadeh M; Melli MS; Shobeiri MJ
    Gynecol Obstet Invest; 2008; 66(1):68-72. PubMed ID: 18500169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotyping from invasive cervical cancer in Chile.
    Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
    Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of human papillomavirus types 16 and 18: histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear.
    Rabelo-Santos SH; Villa LL; Derchain SF; Ferreira S; Sarian LO; Angelo-Andrade LA; do Amaral Westin MC; Zeferino LC
    Int J Gynecol Pathol; 2006 Oct; 25(4):393-7. PubMed ID: 16990718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
    Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus genotypes associated with cervical neoplasia in India.
    Peedicayil A; Abraham P; Sathish N; John S; Shah K; Sridharan G; Gravitt P
    Int J Gynecol Cancer; 2006; 16(4):1591-5. PubMed ID: 16884371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina].
    Sijvarger CC; González JV; Prieto A; Messmer AG; Mallimaci MC; Alonio VL; Teyssié AR; Picconi MA
    Rev Argent Microbiol; 2006; 38(1):19-24. PubMed ID: 16784128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions.
    Chan PK; Li WH; Chan MY; Ma WL; Cheung JL; Cheng AF
    J Med Virol; 1999 Oct; 59(2):232-8. PubMed ID: 10459162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.